Health ❯ Cancer Treatment

Immunotherapy

CAR-T Therapy Cancer Vaccines CAR T Cell Therapy Chronic Inflammation Clinical Trials DDR Inhibitors Botensilimab FDA Regulations Regulatory T-cells mRNA Technology IL-6 Inhibitors Immune Checkpoint Blockade Surgery Targeted Therapies Chemotherapy Vaccine Design Cellular Therapy Tumor Shrinkage Therapeutic Interventions Patient Care T Regulatory Cells mRNA Vaccines Cold Tumors Tumor Microenvironment Side Effects

ImmunityBio Securities Fight Intensifies After FDA Rebuke Over Anktiva Claims

Investor law firms are stepping up recruitment ahead of the court deadline to seek lead‑plaintiff status.

Investor Lawsuits Build After FDA Rebukes ImmunityBio Over Anktiva Promotion

Brain Reward Training Linked to Higher Antibody Response After Hepatitis B Vaccine

OxLDL-Targeted CAR Tregs Cut Mouse Plaque 70% in Penn Study, Prompting Cartio Therapeutics

UW Engineers Program Proteins to Make Logic‑Gated Decisions for Targeted Drug Delivery

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform

Teddi Mellencamp Takes Immunotherapy Break After Scans Show Tumor Shrinkage

UCSF and Stanford Secure $100 Million Weill Matching Gift to Launch $200 Million West Coast Cancer Hub